Central Clinical Hospital #2

Moscow 129128

0 studies enrolling now · 1 studies all time

What they study most

Non Small Cell Lung Cancer

Studies at this site

• A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed